$LFST
LifeStance Health Group, Inc.

2023 Q2 Form 10-Q Financial Statement

#000095017023020544 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $259.6M $252.6M $203.1M
YoY Change 23.89% 24.37% 41.89%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $101.9M $84.63M $103.4M
YoY Change -1.65% -18.13% 216.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.354M $8.896M $5.727M
YoY Change 38.58% 55.33% 119.51%
% of Gross Profit
Operating Expenses $308.0M $286.7M $267.9M
YoY Change 14.07% 6.99% 86.06%
Operating Profit -$48.41M -$34.09M -$64.85M
YoY Change -19.94% -47.43% 7261.07%
Interest Expense $5.119M $5.092M $3.441M
YoY Change -28.23% 47.98% -60.14%
% of Operating Profit
Other Income/Expense, Net -$3.607M -$4.186M -$4.153M
YoY Change -50.8% 0.79% -60.68%
Pretax Income -$52.02M -$38.28M -$69.00M
YoY Change -23.28% -44.53% 503.02%
Income Tax -$6.542M -$4.037M -$6.676M
% Of Pretax Income
Net Earnings -$45.48M -$34.24M -$62.33M
YoY Change -33.83% -45.06% 617.9%
Net Earnings / Revenue -17.52% -13.56% -30.69%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.13 -$0.09 -$177.6K
COMMON SHARES
Basic Shares Outstanding 376.8M 376.4M 374.3M
Diluted Shares Outstanding 363.2K 360.9K 350.8K

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.61M $68.29M $114.0M
YoY Change -17.67% -40.09% 188.63%
Cash & Equivalents $79.61M $68.29M $114.0M
Short-Term Investments
Other Short-Term Assets $36.48M $25.83M $54.32M
YoY Change -23.78% -52.44% 143.39%
Inventory
Prepaid Expenses
Receivables $121.8M $118.4M $94.99M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $237.9M $212.5M $263.3M
YoY Change -2.62% -19.29% 140.28%
LONG-TERM ASSETS
Property, Plant & Equipment $193.1M $193.5M $170.9M
YoY Change 1.28% 13.21% 141.42%
Goodwill $1.294B $1.294B $1.229B
YoY Change 4.0% 5.23%
Intangibles $243.8M $254.0M $291.2M
YoY Change -13.58% -12.78%
Long-Term Investments
YoY Change
Other Assets $11.22M $8.772M $3.679M
YoY Change 42.25% 138.43% 25.73%
Total Long-Term Assets $1.933B $1.946B $1.695B
YoY Change 12.1% 14.81% 13.25%
TOTAL ASSETS
Total Short-Term Assets $237.9M $212.5M $263.3M
Total Long-Term Assets $1.933B $1.946B $1.695B
Total Assets $2.171B $2.159B $1.958B
YoY Change 10.27% 10.22% 21.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.044M $7.709M $15.14M
YoY Change -37.84% -49.07% 155.98%
Accrued Expenses $158.9M $157.3M $95.01M
YoY Change 81.8% 65.6% 33.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.595M $2.345M $1.323M
YoY Change 73.0% 77.25%
Total Short-Term Liabilities $180.9M $181.1M $125.6M
YoY Change 62.14% 44.22% 29.81%
LONG-TERM LIABILITIES
Long-Term Debt $248.7M $224.8M $177.4M
YoY Change 22.3% 26.71% -54.2%
Other Long-Term Liabilities $2.559M $2.059M $57.49M
YoY Change -96.03% -96.42% 277.14%
Total Long-Term Liabilities $495.2M $472.3M $290.3M
YoY Change 51.97% 62.71% -27.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $180.9M $181.1M $125.6M
Total Long-Term Liabilities $495.2M $472.3M $290.3M
Total Liabilities $676.0M $653.4M $415.9M
YoY Change 54.57% 57.13% -28.36%
SHAREHOLDERS EQUITY
Retained Earnings -$654.3M -$608.8M -$419.4M
YoY Change 34.04% 45.17%
Common Stock $2.145B $2.112B $1.962B
YoY Change 6.22% 7.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.495B $1.505B $1.543B
YoY Change
Total Liabilities & Shareholders Equity $2.171B $2.159B $1.958B
YoY Change 10.27% 10.22% 21.92%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$45.48M -$34.24M -$62.33M
YoY Change -33.83% -45.06% 617.9%
Depreciation, Depletion And Amortization $9.354M $8.896M $5.727M
YoY Change 38.58% 55.33% 119.51%
Cash From Operating Activities -$434.0K -$7.890M $3.308M
YoY Change -105.54% -338.51% -66.62%
INVESTING ACTIVITIES
Capital Expenditures $11.58M $7.729M $27.91M
YoY Change -144.77% -72.31% 151.87%
Acquisitions $19.82M $22.95M
YoY Change -13.62% 2943.1%
Other Investing Activities $0.00 -$19.82M -$22.95M
YoY Change -100.0% -13.62% 2943.1%
Cash From Investing Activities -$11.58M -$27.55M -$50.86M
YoY Change -69.55% -45.83% 329.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $586.0K $331.0K
YoY Change 77.04% -57.83%
Cash From Financing Activities 23.33M -4.888M 13.51M
YoY Change 80.81% -136.19% -40.21%
NET CHANGE
Cash From Operating Activities -434.0K -7.890M 3.308M
Cash From Investing Activities -11.58M -27.55M -50.86M
Cash From Financing Activities 23.33M -4.888M 13.51M
Net Change In Cash 11.31M -40.33M -34.04M
YoY Change -165.37% 18.47% -264.72%
FREE CASH FLOW
Cash From Operating Activities -$434.0K -$7.890M $3.308M
Capital Expenditures $11.58M $7.729M $27.91M
Free Cash Flow -$12.02M -$15.62M -$24.60M
YoY Change -135.65% -36.51% 1999.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001845257
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-40478
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LifeStance Health Group, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1832801
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4800 N. Scottsdale Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 6000
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
CY2023Q1 dei City Area Code
CityAreaCode
602
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
767-2100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
LFST
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
376764734
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68294000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108621000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
118382000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100868000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25833000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23734000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
212509000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
233223000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193511000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
194189000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
196193000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
199431000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
253964000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
263294000
CY2023Q1 us-gaap Goodwill
Goodwill
1293613000
CY2022Q4 us-gaap Goodwill
Goodwill
1272939000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8772000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10795000
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
1946053000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1940648000
CY2023Q1 us-gaap Assets
Assets
2158562000
CY2022Q4 us-gaap Assets
Assets
2173871000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7709000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12285000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83673000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
75650000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
32022000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30428000
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
13257000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
15876000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41647000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38824000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2833000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2936000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
181141000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
175999000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
224761000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
225079000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
207903000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
212586000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
37569000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
38701000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2059000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2783000
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
472292000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
479149000
CY2023Q1 us-gaap Liabilities
Liabilities
653433000
CY2022Q4 us-gaap Liabilities
Liabilities
655148000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
376537000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
376537000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
375964000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
375964000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
3767000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3761000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2108184000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2084324000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2004000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3274000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-608826000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-572636000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1505129000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1518723000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2158562000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2173871000
CY2023Q1 us-gaap Revenues
Revenues
252589000
CY2022Q1 us-gaap Revenues
Revenues
203095000
CY2023Q1 us-gaap Other General Expense
OtherGeneralExpense
182987000
CY2022Q1 us-gaap Other General Expense
OtherGeneralExpense
148893000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
84626000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
103369000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19069000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15684000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
286682000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
267946000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-34093000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-64851000
CY2023Q1 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
1037000
CY2022Q1 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-434000
CY2023Q1 lfst Transaction Costs
TransactionCosts
86000
CY2022Q1 lfst Transaction Costs
TransactionCosts
278000
CY2023Q1 us-gaap Interest Expense
InterestExpense
5092000
CY2022Q1 us-gaap Interest Expense
InterestExpense
3441000
CY2023Q1 us-gaap Other Expenses
OtherExpenses
45000
CY2022Q1 us-gaap Other Expenses
OtherExpenses
0
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4186000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4153000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38279000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-69004000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4037000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6676000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34242000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-62328000
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.09
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.18
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.18
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
360902
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
360902
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
350849
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
350849
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34242000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-62328000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1270000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35512000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62328000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1518723000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34242000
CY2023Q1 lfst Adoption Of Asu Two Zero One Six To One Three
AdoptionOfAsuTwoZeroOneSixToOneThree
-1948000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3365000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1270000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27231000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1505129000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1545028000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-62328000
CY2022Q1 lfst Stock Issued During Period Value Restricted Stock Units Releases
StockIssuedDuringPeriodValueRestrictedStockUnitsReleases
-37000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-185000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60040000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1542518000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-34242000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-62328000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19069000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15684000
CY2023Q1 lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
10113000
CY2022Q1 lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
0
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
23866000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
59855000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
549000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
295000
CY2023Q1 lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
1037000
CY2022Q1 lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-434000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-45000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17138000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18121000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4543000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12065000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5466000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1852000
CY2023Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
7663000
CY2022Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
12759000
CY2023Q1 lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-8736000
CY2022Q1 lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1967000
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4943000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7890000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3308000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7729000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27910000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19820000
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
22945000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27549000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50855000
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20000000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
586000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
331000
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4302000
CY2022Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5720000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
441000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4888000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13508000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40327000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34039000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108621000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148029000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68294000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113990000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
5059000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
3091000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-13000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-60000
CY2023Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0
CY2022Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
57000
CY2023Q1 lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
1985000
CY2022Q1 lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
2470000
CY2023Q1 lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
8297000
CY2022Q1 lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
12320000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Accounting Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q1 lfst Acquisition Of Non Medical Assets
AcquisitionOfNonMedicalAssets
1
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
252589000
CY2023Q1 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
203095000
CY2022Q1 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
244244000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
237072000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50733000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42883000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193511000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
194189000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8896000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5727000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
14308000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
0
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0662
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0647
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
15339000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6878000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
40751000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
62902000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
58925000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
51403000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
38149000
CY2023Q1 lfst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
44781000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
296911000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
47361000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
249550000
CY2022Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
11546000
CY2022Q4 us-gaap Goodwill
Goodwill
1272939000
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
20733000
CY2023Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-59000
CY2023Q1 us-gaap Goodwill
Goodwill
1293613000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
366729000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
112765000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
253964000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
365886000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
102592000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
263294000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10173000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9957000
CY2023Q1 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
3
CY2022Q1 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
2
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
181000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
421000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
372000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
486000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
138000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
64000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
221000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
34000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
368000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
0
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
22000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
3000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
843000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
782000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
20733000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
24701000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
22878000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
26491000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
893000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
696000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
21985000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
25795000
CY2023Q1 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
843000
CY2022Q1 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
782000
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
57100000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
4426000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17824000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17430000
CY2023Q1 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
1985000
CY2022 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
11221000
CY2023Q1 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-4302000
CY2022 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-12515000
CY2023Q1 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
-1037000
CY2022 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
1688000
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
14470000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17824000
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
14470000
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
17824000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
233378000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
233964000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2345000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2345000
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6272000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6540000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
224761000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
225079000
CY2023Q1 us-gaap Interest Expense
InterestExpense
5092000
CY2022Q1 us-gaap Interest Expense
InterestExpense
3441000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
1759000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2345000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2345000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
2345000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
2345000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
222239000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
233378000
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
237451000
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
235049
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
23866000
CY2022Q1 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
59855000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
233046
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4037000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6676000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.105
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.097
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1424000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1424000
CY2023Q1 us-gaap Malpractice Insurance Coverage Floor
MalpracticeInsuranceCoverageFloor
3000000
CY2023Q1 us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
8000000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34242000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-62328000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
360902
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
350849
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.09
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.18
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.18
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57271
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39029

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-23-020544-index-headers.html Edgar Link pending
0000950170-23-020544-index.html Edgar Link pending
0000950170-23-020544.txt Edgar Link pending
0000950170-23-020544-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lfst-20230331.htm Edgar Link pending
lfst-20230331.xsd Edgar Link pending
lfst-ex31_1.htm Edgar Link pending
lfst-ex31_2.htm Edgar Link pending
lfst-ex32_1.htm Edgar Link pending
lfst-20230331_cal.xml Edgar Link unprocessable
lfst-20230331_def.xml Edgar Link unprocessable
lfst-20230331_pre.xml Edgar Link unprocessable
lfst-20230331_lab.xml Edgar Link unprocessable
lfst-20230331_htm.xml Edgar Link completed
lfst-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending